Among CEBPs, CEBPA, CEBPE and CEBPZ have been reported to function in AML development [9, 19, 20], however the role of CCAAT enhancer binding protein gamma (CEBPG) in AML is unclear. Here, CEBPG is linked to acute myeloid leukemia.